References

1. Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Di Napoli R. Features, evaluation and treatment coronavirus (COVID-19). Statpearls [internet]: StatPearls Publishing; 2020.
2. Li H, Liu S-M, Yu X-H, Tang S-L, Tang C-K. Coronavirus disease 2019 (COVID-19): current status and future perspectives. Int J Antimicrob Agents. 2020:105951-.
3. Petrosillo N, Viceconte G, Ergonul O, Ippolito G, Petersen E. COVID-19, SARS and MERS: are they closely related? Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2020.
4. Singhal T. A Review of Coronavirus Disease-2019 (COVID-19). Indian journal of pediatrics. 2020;87(4):281-6.
5. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020;395(10223):497-506.
6. Sachdeva M, Gianotti R, Shah M, Lucia B, Tosi D, Veraldi S, et al. Cutaneous manifestations of COVID-19: Report of three cases and a review of literature. J Dermatol Sci. 2020:S0923-1811(20)30149-3.
7. WHO. Coronavirus disease 2019 (COVID-19) Situation Report - 114 2020 [Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200513-covid-19-sitrep-114.pdf?sfvrsn=17ebbbe_4.
8. Shetty R, Ghosh A, Honavar SG, Khamar P, Sethu S. Therapeutic opportunities to manage COVID-19/SARS-CoV-2 infection: Present and future. Indian journal of ophthalmology. 2020;68(5):693.
9. ClinicalTrials.gov. A Study of Hydroxychloroquine, Vitamin C, Vitamin D, and Zinc for the Prevention of COVID-19 Infection: https://ClinicalTrials.gov/show/NCT04335084; 2020 [
10. Rondanelli M, Miccono A, Lamburghini S, Avanzato I, Riva A, Allegrini P, et al. Self-Care for Common Colds: The Pivotal Role of Vitamin D, Vitamin C, Zinc, and Echinacea in Three Main Immune Interactive Clusters (Physical Barriers, Innate and Adaptive Immunity) Involved during an Episode of Common Colds-Practical Advice on Dosages and on the Time to Take These Nutrients/Botanicals in order to Prevent or Treat Common Colds. Evid Based Complement Alternat Med. 2018;2018:5813095-.
11. Shah D, Gupta P. Vitamin D Deficiency: Is The Pandemic for Real? Indian J Community Med. 2015;40(4):215-7.
12. Holick MF. The vitamin D deficiency pandemic: Approaches for diagnosis, treatment and prevention. Reviews in endocrine & metabolic disorders. 2017;18(2):153-65.
13. Wang H, Chen W, Li D, Yin X, Zhang X, Olsen N, et al. Vitamin D and Chronic Diseases. Aging Dis. 2017;8(3):346-53.
14. Holick MF. Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. The American journal of clinical nutrition. 2004;79(3):362-71.
15. Bikle DD. Vitamin D metabolism, mechanism of action, and clinical applications. Chem Biol. 2014;21(3):319-29.
16. Morris HA, Anderson PH. Autocrine and paracrine actions of vitamin d. Clin Biochem Rev. 2010;31(4):129-38.
17. Prietl B, Treiber G, Pieber TR, Amrein K. Vitamin D and immune function. Nutrients. 2013;5(7):2502-21.
18. Wacker M, Holick MF. Sunlight and Vitamin D: A global perspective for health. Dermatoendocrinol. 2013;5(1):51-108.
19. Vashi PG, Trukova K, Lammersfeld CA, Braun DP, Gupta D. Impact of oral vitamin D supplementation on serum 25-hydroxyvitamin D levels in oncology. Nutrition Journal. 2010;9(1):60.
20. Gowda U, Ruwanpathirana T, Fong DPS, Kaur A, Renzaho AMN. Efficacy of high dose Vitamin D supplementation in improving serum 25(OH)D among migrant and non migrant population: a retrospective study. BMC Health Services Research. 2016;16(1):579.
21. Zhang R, Naughton DP. Vitamin D in health and disease: current perspectives. Nutrition journal. 2010;9:65-.
22. Nair R, Maseeh A. Vitamin D: The ”sunshine” vitamin. J Pharmacol Pharmacother. 2012;3(2):118-26.
23. Hewison M. Antibacterial effects of vitamin D. Nature Reviews Endocrinology. 2011;7(6):337.
24. Khoo AL, Chai L, Koenen H, Joosten I, Netea M, van der Ven A. Translating the role of vitamin D3 in infectious diseases. Critical reviews in microbiology. 2012;38(2):122-35.
25. Mangin M, Sinha R, Fincher K. Inflammation and vitamin D: the infection connection. Inflammation Research. 2014;63(10):803-19.
26. White JH. Vitamin D metabolism and signaling in the immune system. Reviews in endocrine and metabolic disorders. 2012;13(1):21-9.
27. Nouari W, Ysmail-Dahlouk L, Aribi M. Vitamin D3 enhances bactericidal activity of macrophage against Pseudomonas aeruginosa. International immunopharmacology. 2016;30:94-101.
28. Beard JA, Bearden A, Striker R. Vitamin D and the anti-viral state. J Clin Virol. 2011;50(3):194-200.
29. Zasloff M. Fighting infections with vitamin D. Nature medicine. 2006;12(4):388-90.
30. Turner J, Cho Y, Dinh N-N, Waring AJ, Lehrer RI. Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils. Antimicrobial agents and chemotherapy. 1998;42(9):2206-14.
31. Hazrati E, Galen B, Lu W, Wang W, Ouyang Y, Keller MJ, et al. Human α- and β-Defensins Block Multiple Steps in Herpes Simplex Virus Infection. The Journal of Immunology. 2006;177(12):8658-66.
32. Yasin B, Wang W, Pang M, Cheshenko N, Hong T, Waring AJ, et al. θ Defensins Protect Cells from Infection by Herpes Simplex Virus by Inhibiting Viral Adhesion and Entry. Journal of Virology. 2004;78(10):5147-56.
33. Tripathi S, Tecle T, Verma A, Crouch E, White M, Hartshorn KL. The human cathelicidin LL-37 inhibits influenza A viruses through a mechanism distinct from that of surfactant protein D or defensins. J Gen Virol. 2013;94(Pt 1):40-9.
34. Aranow C. Vitamin D and the immune system. J Investig Med. 2011;59(6):881-6.
35. Gil A, Plaza-Diaz J, Mesa MD. Vitamin D: classic and novel actions. Annals of Nutrition and Metabolism. 2018;72(2):87-95.
36. Szymczak I, Pawliczak R. The Active Metabolite of Vitamin D3 as a Potential Immunomodulator. Scandinavian Journal of Immunology. 2016;83(2):83-91.
37. Zheng S, Yang J, Hu X, Li M, Wang Q, Dancer RCA, et al. Vitamin D attenuates lung injury via stimulating epithelial repair, reducing epithelial cell apoptosis and inhibits TGF-β induced epithelial to mesenchymal transition. Biochemical Pharmacology. 2020:113955.
38. Dancer RCA, Parekh D, Lax S, D’Souza V, Zheng S, Bassford CR, et al. Vitamin D deficiency contributes directly to the acute respiratory distress syndrome (ARDS). Thorax. 2015;70(7):617-24.
39. Xu J, Yang J, Chen J, Luo Q, Zhang Q, Zhang H. Vitamin D alleviates lipopolysaccharide‑induced acute lung injury via regulation of the renin‑angiotensin system. Molecular medicine reports. 2017;16(5):7432-8.
40. Hileman CO, Overton ET, McComsey GA. Vitamin D and bone loss in HIV. Current Opinion in HIV and AIDS. 2016;11(3):277.
41. Alvarez N, Aguilar-Jimenez W, Rugeles MT. The Potential Protective Role of Vitamin D Supplementation on HIV-1 Infection. Front Immunol. 2019;10(2291).
42. Lake JE, Adams JS. Vitamin D in HIV-Infected Patients. Curr HIV/AIDS Rep. 2011;8(3):133-41.
43. Okoye AA, Picker LJ. CD 4+ T‐cell depletion in HIV infection: mechanisms of immunological failure. Immunological reviews. 2013;254(1):54-64.
44. Abraham AG, Zhang L, Calkins K, Tin A, Hoofnagle A, Palella FJ, Jr., et al. Vitamin D status and immune function reconstitution in HIV-infected men initiating therapy. AIDS (London, England). 2018;32(8):1069-76.
45. Jiménez-Sousa MÁ, Martínez I, Medrano LM, Fernández-Rodríguez A, Resino S. Vitamin D in human immunodeficiency virus infection: influence on immunity and disease. Front Immunol. 2018;9:458.
46. Mansueto P, Seidita A, Vitale G, Gangemi S, Iaria C, Cascio A. Vitamin D Deficiency in HIV Infection: Not Only a Bone Disorder. Biomed Res Int. 2015;2015:735615-.
47. Jiménez-Sousa MÁ, Martínez I, Medrano LM, Fernández-Rodríguez A, Resino S. Vitamin D in Human Immunodeficiency Virus Infection: Influence on Immunity and Disease. Front Immunol. 2018;9:458-.
48. Coelho L, Cardoso SW, Luz PM, Hoffman RM, Mendonça L, Veloso VG, et al. Vitamin D3 supplementation in HIV infection: effectiveness and associations with antiretroviral therapy. Nutrition Journal. 2015;14(1):81.
49. Connor RI, Rigby WF. 1 alpha,25-dihydroxyvitamin D3 inhibits productive infection of human monocytes by HIV-1. Biochemical and biophysical research communications. 1991;176(2):852-9.
50. Schuitemaker H, Kootstra NA, Koppelman MH, Bruisten SM, Huisman HG, Tersmette M, et al. Proliferation-dependent HIV-1 infection of monocytes occurs during differentiation into macrophages. The Journal of clinical investigation. 1992;89(4):1154-60.
51. Villar LM, Del Campo JA, Ranchal I, Lampe E, Romero-Gomez M. Association between vitamin D and hepatitis C virus infection: a meta-analysis. World journal of gastroenterology. 2013;19(35):5917-24.
52. Gutierrez JA, Jones KA, Flores R, Singhania A, Woelk CH, Schooley RT, et al. Vitamin D Metabolites Inhibit Hepatitis C Virus and Modulate Cellular Gene Expression. J Virol Antivir Res. 2014;3(3):10.4172/2324-8955.1000129.
53. Vankadari N, Wilce JA. Emerging WuHan (COVID-19) coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26. Emerging microbes & infections. 2020;9(1):601-4.
54. McCartney D, Byrne D. Optimisation of Vitamin D Status for Enhanced Immuno-protection Against Covid-19.
55. Komolmit P, Kimtrakool S, Suksawatamnuay S, Thanapirom K, Chattrasophon K, Thaimai P, et al. Vitamin D supplementation improves serum markers associated with hepatic fibrogenesis in chronic hepatitis C patients: A randomized, double-blind, placebo-controlled study. Scientific Reports. 2017;7(1):8905.
56. Hewings-Martin Y. How do SARS and MERS compare with COVID-19? [Newsletter]. MEDICALNEWSTODAY; 2020 [updated 10 April 2020. Available from: https://www.medicalnewstoday.com/articles/how-do-sars-and-mers-compare-with-covid-19.
57. Yuki K, Fujiogi M, Koutsogiannaki S. COVID-19 pathophysiology: A review. Clin Immunol. 2020:108427.
58. Martineau AR, Jolliffe DA, Hooper RL, Greenberg L, Aloia JF, Bergman P, et al. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ. 2017;356:i6583.
59. Storms AD, Chen J, Jackson LA, Nordin JD, Naleway AL, Glanz JM, et al. Rates and risk factors associated with hospitalization for pneumonia with ICU admission among adults. BMC Pulm Med. 2017;17(1):208-.
60. Marston BJ, Plouffe JF, File TM, Jr., Hackman BA, Salstrom SJ, Lipman HB, et al. Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based active surveillance Study in Ohio. The Community-Based Pneumonia Incidence Study Group. Archives of internal medicine. 1997;157(15):1709-18.
61. Jat KR. Vitamin D deficiency and lower respiratory tract infections in children: a systematic review and meta-analysis of observational studies. Tropical doctor. 2017;47(1):77-84.
62. Berry DJ, Hesketh K, Power C, Hypponen E. Vitamin D status has a linear association with seasonal infections and lung function in British adults. The British journal of nutrition. 2011;106(9):1433-40.
63. Ginde AA, Mansbach JM, Camargo CA, Jr. Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Archives of internal medicine. 2009;169(4):384-90.
64. Sabetta JR, DePetrillo P, Cipriani RJ, Smardin J, Burns LA, Landry ML. Serum 25-hydroxyvitamin d and the incidence of acute viral respiratory tract infections in healthy adults. PLoS One. 2010;5(6):e11088.
65. Laaksi I, Ruohola JP, Tuohimaa P, Auvinen A, Haataja R, Pihlajamaki H, et al. An association of serum vitamin D concentrations < 40 nmol/L with acute respiratory tract infection in young Finnish men. Am J Clin Nutr. 2007;86(3):714-7.
66. Manaseki-Holland S, Qader G, Isaq Masher M, Bruce J, Zulf Mughal M, Chandramohan D, et al. Effects of vitamin D supplementation to children diagnosed with pneumonia in Kabul: a randomised controlled trial. Tropical medicine & international health : TM & IH. 2010;15(10):1148-55.
67. Camargo CA, Jr., Ganmaa D, Frazier AL, Kirchberg FF, Stuart JJ, Kleinman K, et al. Randomized trial of vitamin D supplementation and risk of acute respiratory infection in Mongolia. Pediatrics. 2012;130(3):e561-7.
68. Choudhary N, Gupta P. Vitamin D supplementation for severe pneumonia–a randomized controlled trial. Indian pediatrics. 2012;49(6):449-54.
69. Manaseki-Holland S, Maroof Z, Bruce J, Mughal MZ, Masher MI, Bhutta ZA, et al. Effect on the incidence of pneumonia of vitamin D supplementation by quarterly bolus dose to infants in Kabul: a randomised controlled superiority trial. Lancet (London, England). 2012;379(9824):1419-27.
70. Das RR, Singh M, Panigrahi I, Naik SS. Vitamin D supplementation for the treatment of acute childhood pneumonia: a systematic review. ISRN pediatrics. 2013;2013.
71. Zittermann A, Pilz S, Hoffmann H, März W. Vitamin D and airway infections: a European perspective. European journal of medical research. 2016;21(1):14.
72. Urashima M, Segawa T, Okazaki M, Kurihara M, Wada Y, Ida H. Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. Am J Clin Nutr. 2010;91(5):1255-60.
73. Kearns MD, Alvarez JA, Seidel N, Tangpricha V. Impact of vitamin D on infectious disease. Am J Med Sci. 2015;349(3):245-62.
74. Cannell JJ, Vieth R, Umhau JC, Holick MF, Grant WB, Madronich S, et al. Epidemic influenza and vitamin D. Epidemiology and infection. 2006;134(6):1129-40.
75. Karatekin G, Kaya A, Salihoglu O, Balci H, Nuhoglu A. Association of subclinical vitamin D deficiency in newborns with acute lower respiratory infection and their mothers. European journal of clinical nutrition. 2009;63(4):473-7.
76. Roth DE, Shah R, Black RE, Baqui AH. Vitamin D status and acute lower respiratory infection in early childhood in Sylhet, Bangladesh. Acta paediatrica (Oslo, Norway : 1992). 2010;99(3):389-93.
77. Hurwitz JL, Jones BG, Penkert RR, Gansebom S, Sun Y, Tang L, et al. Low Retinol-Binding Protein and Vitamin D Levels Are Associated with Severe Outcomes in Children Hospitalized with Lower Respiratory Tract Infection and Respiratory Syncytial Virus or Human Metapneumovirus Detection. J Pediatr. 2017;187:323-7.
78. Walker VP, Modlin RL. The vitamin D connection to pediatric infections and immune function. Pediatr Res. 2009;65(5 Pt 2):106R-13R.
79. Halasa N, Williams J, Faouri S, Shehabi A, Vermund SH, Wang L, et al. Natural history and epidemiology of respiratory syncytial virus infection in the Middle East: Hospital surveillance for children under age two in Jordan. Vaccine. 2015;33(47):6479-87.
80. Quraishi SA, Bittner EA, Christopher KB, Camargo Jr CA. Vitamin D status and community-acquired pneumonia: results from the third National Health and Nutrition Examination Survey. PLoS One. 2013;8(11).
81. Pletz MW, Terkamp C, Schumacher U, Rohde G, Schütte H, Welte T, et al. Vitamin D deficiency in community-acquired pneumonia: low levels of 1,25(OH)2 D are associated with disease severity. Respiratory Research. 2014;15(1):53.
82. Perez MO, Oliveira RM, Levy-Neto M, Caparbo VF, Pereira RMR. Serum 25-hydroxyvitamin D levels in patients with Granulomatosis with Polyangiitis: association with respiratory infection. Clinics (Sao Paulo). 2017;72(12):723-8.
83. Hansdottir S, Monick MM. Chapter Nine - Vitamin D Effects on Lung Immunity and Respiratory Diseases. In: Litwack G, editor. Vitamins & Hormones. 86: Academic Press; 2011. p. 217-37.
84. Daneshkhah A, Agrawal V, Eshein A, Subramanian H, Roy HK, Backman V. The Possible Role of Vitamin D in Suppressing Cytokine Storm and Associated Mortality in COVID-19 Patients. medRxiv. 2020:2020.04.08.20058578.
85. Robinson AB, Tangpricha V, Yow E, Gurion R, McComsey GA, Schanberg LE. Vitamin D deficiency is common and associated with increased C-reactive protein in children and young adults with lupus: an Atherosclerosis Prevention in Pediatric Lupus Erythematosus substudy. Lupus Sci Med. 2014;1(1):e000011.
86. Liefaard MC, Ligthart S, Vitezova A, Hofman A, Uitterlinden AG, Kiefte-de Jong JC, et al. Vitamin D and C-Reactive Protein: A Mendelian Randomization Study. PLoS One. 2015;10(7):e0131740-e.
87. Li Q, Dai Z, Cao Y, Wang L. Association of C-reactive protein and vitamin D deficiency with cardiovascular disease: A nationwide cross-sectional study from National Health and Nutrition Examination Survey 2007 to 2008. Clinical cardiology. 2019;42(7):663-9.
88. Chandler PD, Scott JB, Drake BF, Ng K, Manson JE, Rifai N, et al. Impact of vitamin D supplementation on inflammatory markers in African Americans: results of a four-arm, randomized, placebo-controlled trial. Cancer prevention research. 2014;7(2):218-25.
89. Mazidi M, Rezaie P, Vatanparast H. Impact of vitamin D supplementation on C-reactive protein; a systematic review and meta-analysis of randomized controlled trials. BMC Nutrition. 2018;4(1):1.
90. Xu S, Song J, Zhang Z-H, Fu L, Gao L, Xie D-D, et al. The Vitamin D status is associated with serum C-reactive protein and adhesion molecules in patients with renal cell carcinoma. Scientific Reports. 2019;9(1):16719.
91. Robinson AB, Tangpricha V, Yow E, Gurion R, McComsey GA, Schanberg LE, et al. Vitamin D deficiency is common and associated with increased C-reactive protein in children and young adults with lupus: an Atherosclerosis Prevention in Pediatric Lupus Erythematosus substudy. Lupus science & medicine. 2014;1(1):e000011.
92. Luo X, Zhou W, Yan X, Guo T, Wang B, Xia H, et al. Prognostic value of C-reactive protein in patients with COVID-192020.
93. Wang L. C-reactive protein levels in the early stage of COVID-19. Medecine et maladies infectieuses. 2020.
94. McMullan CJ, Borgi L, Curhan GC, Fisher N, Forman JP. The Effect of Vitamin D on Renin-Angiotensin-System Activation and Blood Pressure-A Randomized Control Trial. Journal of hypertension. 2017;35(4):822.
95. Li YC, Qiao G, Uskokovic M, Xiang W, Zheng W, Kong J. Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure. The Journal of steroid biochemistry and molecular biology. 2004;89-90(1-5):387-92.
96. Li YC, Qiao G, Uskokovic M, Xiang W, Zheng W, Kong J. Vitamin D: a negative endocrine regulator of the renin–angiotensin system and blood pressure. The Journal of steroid biochemistry and molecular biology. 2004;89:387-92.
97. Zittermann A, Ernst JB, Prokop S, Fuchs U, Dreier J, Kuhn J, et al. Effects of vitamin D supplementation on renin and aldosterone concentrations in patients with advanced heart failure: the EVITA trial. International journal of endocrinology. 2018;2018.
98. Li Y. Vitamin D regulation of the renin-angiotensin system. Journal of cellular biochemistry. 2003;88:327-31.
99. Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ. COVID-19: consider cytokine storm syndromes and immunosuppression. The Lancet. 2020;395(10229):1033-4.
100. Heine G, Niesner U, Chang HD, Steinmeyer A, Zügel U, Zuberbier T, et al. 1, 25‐dihydroxyvitamin D3 promotes IL‐10 production in human B cells. European journal of immunology. 2008;38(8):2210-8.
101. Adams JS, Hewison M. Update in vitamin D. The Journal of clinical endocrinology and metabolism. 2010;95(2):471-8.
102. Smolders J, Thewissen M, Peelen E, Menheere P, Tervaert JW, Damoiseaux J, et al. Vitamin D status is positively correlated with regulatory T cell function in patients with multiple sclerosis. PLoS One. 2009;4(8):e6635.
103. Lin Z, Li W. The Roles of Vitamin D and Its Analogs in Inflammatory Diseases. Current topics in medicinal chemistry. 2016;16(11):1242-61.
104. Zhang Y, Leung DY, Richers BN, Liu Y, Remigio LK, Riches DW, et al. Vitamin D inhibits monocyte/macrophage proinflammatory cytokine production by targeting MAPK phosphatase-1. Journal of immunology (Baltimore, Md : 1950). 2012;188(5):2127-35.
105. Topilski I, Flaishon L, Naveh Y, Harmelin A, Levo Y, Shachar I. The anti-inflammatory effects of 1,25-dihydroxyvitamin D3 on Th2 cells in vivo are due in part to the control of integrin-mediated T lymphocyte homing. European journal of immunology. 2004;34(4):1068-76.
106. Musselwhite LW, Andrade BB, Ellenberg SS, Tierney A, Belaunzaran-Zamudio PF, Rupert A, et al. Vitamin D, d-dimer, Interferon γ, and sCD14 Levels are Independently Associated with Immune Reconstitution Inflammatory Syndrome: A Prospective, International Study. EBioMedicine. 2016;4:115-23.
107. Fabre-Mersseman V, Tubiana R, Papagno L, Bayard C, Briceno O, Fastenackels S, et al. Vitamin D supplementation is associated with reduced immune activation levels in HIV-1-infected patients on suppressive antiretroviral therapy. AIDS (London, England). 2014;28(18):2677-82.
108. Baeke F, Takiishi T, Korf H, Gysemans C, Mathieu C. Vitamin D: modulator of the immune system. Current Opinion in Pharmacology. 2010;10(4):482-96.
109. Yang J, Tian G, Chen D, Zheng P, Yu J, Mao X, et al. Dietary 25-Hydroxyvitamin D(3) Supplementation Alleviates Porcine Epidemic Diarrhea Virus Infection by Improving Intestinal Structure and Immune Response in Weaned Pigs. Animals (Basel). 2019;9(9):627.
110. Tian G, Liang X, Chen D, Mao X, Yu J, Zheng P, et al. Vitamin D3 supplementation alleviates rotavirus infection in pigs and IPEC-J2 cells via regulating the autophagy signaling pathway. The Journal of steroid biochemistry and molecular biology. 2016;163:157-63.
111. Yuk JM, Shin DM, Lee HM, Yang CS, Jin HS, Kim KK, et al. Vitamin D3 induces autophagy in human monocytes/macrophages via cathelicidin. Cell host & microbe. 2009;6(3):231-43.
112. Shi YY, Liu TJ, Fu JH, Xu W, Wu LL, Hou AN, et al. Vitamin D/VDR signaling attenuates lipopolysaccharide‑induced acute lung injury by maintaining the integrity of the pulmonary epithelial barrier. Molecular medicine reports. 2016;13(2):1186-94.
113. Esposito S, Lelii M. Vitamin D and respiratory tract infections in childhood. BMC Infect Dis. 2015;15:487-.
114. Bergman P, Lindh AU, Björkhem-Bergman L, Lindh JD. Vitamin D and Respiratory Tract Infections: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. PLoS One. 2013;8(6):e65835-e.
115. Heaney RP. Vitamin D–baseline status and effective dose. The New England journal of medicine. 2012;367(1):77-8.
116. Martineau AR. Bolus-dose vitamin D and prevention of childhood pneumonia. Lancet (London, England). 2012;379(9824):1373-5.
117. Hollis BW. Short-term and long-term consequences and concerns regarding valid assessment of vitamin D deficiency: comparison of recent food supplementation and clinical guidance reports. Current opinion in clinical nutrition and metabolic care. 2011;14(6):598-604.
118. Schwalfenberg G. Vitamin D for influenza. Canadian Family Physician. 2015;61(6):507-.
119. Alshahrani F, Aljohani N. Vitamin D: deficiency, sufficiency and toxicity. Nutrients. 2013;5(9):3605-16.
120. Schwalfenberg G. Vitamin D for influenza. Can Fam Physician. 2015;61(6):507-.
121. Grant WB, Al Anouti F, Moukayed M. Targeted 25-hydroxyvitamin D concentration measurements and vitamin D3 supplementation can have important patient and public health benefits. European journal of clinical nutrition. 2020;74(3):366-76.
122. Grant WB, Lahore H, McDonnell SL, Baggerly CA, French CB, Aliano JL, et al. Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths. Nutrients. 2020;12(4):988.
123. Vieth R, Kimball S, Hu A, Walfish PG. Randomized comparison of the effects of the vitamin D3 adequate intake versus 100 mcg (4000 IU) per day on biochemical responses and the wellbeing of patients. Nutr J. 2004;3:8.
124. Bischoff-Ferrari HA, Shao A, Dawson-Hughes B, Hathcock J, Giovannucci E, Willett WC. Benefit-risk assessment of vitamin D supplementation. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2010;21(7):1121-32.
125. Sullivan R. Coronavirus: PHE recommends taking vitamin D supplements as lockdown continues [Newspaper]. Independent; 2020 [Available from: https://www.independent.co.uk/news/health/coronavirus-lockdown-uk-england-vitamin-d-intake-phe-a9479401.html.
126. Crowe FL, Jolly K, MacArthur C, Manaseki-Holland S, Gittoes N, Hewison M, et al. Trends in the incidence of testing for vitamin D deficiency in primary care in the UK: a retrospective analysis of The Health Improvement Network (THIN), 2005-2015. BMJ Open. 2019;9(6):e028355-e.
127. Bates B, Cox L, Nicholson S, Page P, Prentice A, Steer T, et al. National Diet and Nutrition Survey results from years 5 and 6 (combined) of the Rolling Programme (2012/2013–2013/2014). London: Public Health England. 2016.